(BBC) — A pair of cancer drugs can shrink tumours in nearly 60% of people with advanced melanoma, a new trial has suggested.
An international trial on 945 patients found treatment with ipilimumab and nivolumab stopped the cancer advancing for nearly a year in 58% of cases.
Advertisement - story continues below
UK doctors presented the data at the American Society of Clinical Oncology.
Cancer Research UK said the drugs deliver a "powerful punch" against one of the most aggressive forms of cancer.